Discovery of cancer gene may predict survival in patients with mouth cancers
Loyola researchers have identified a tumor gene that may help to predict survival outcomes in patients with cancer of the mouth and tongue.
May 4, 2016
0
1
Loyola researchers have identified a tumor gene that may help to predict survival outcomes in patients with cancer of the mouth and tongue.
May 4, 2016
0
1
Children with cerebral palsy frequently undergo invasive surgeries—lengthening tendons, rotating bones, transferring muscles to new locations—in hopes of improving their physical ability to walk or move.
Apr 27, 2016
0
4
Antibiotic resistance is one of the most challenging problems in modern medicine. A new study by Erida Gjini and Patricia H. Brito from the Instituto Gulbenkian de Ciência (IGC; Portugal), provides a new mathematical model ...
Apr 19, 2016
0
1
They describe a wide range of consequences—physical, emotional, social, and vocational—arising from their treatment.
Apr 7, 2016
0
0
Nearly 15 percent of patients diagnosed with colorectal cancer were younger than 50, the age at which screening recommendations begin.
Jan 25, 2016
0
8
An increasing number of men diagnosed with low-risk prostate cancer are opting for active surveillance - closely monitoring their cancer - rather than aggressive treatment to avoid the debilitating potential side effects ...
Dec 1, 2015
0
3
Scientists have identified a new protein (C5orf30) which regulates the severity of tissue damage caused by rheumatoid arthritis (RA), an autoimmune disease that causes inflammation, pain, stiffness and damage to the joints ...
Aug 31, 2015
0
253
Treating both low-density lipoprotein (LDL), or "bad," cholesterol with statins and blood pressure with calcium channel antagonists reduces harmful coronary plaque, according to a new study presented today as a late-breaking ...
May 11, 2015
0
10
A Northwestern University-led study in the emerging field of nanocytology could one day help men make better decisions about whether or not to undergo aggressive prostate cancer treatments.
Mar 16, 2015
0
29
(HealthDay)—Unituxin (dinutuximab) has been approved by the U.S. Food and Drug Administration to treat children with high-risk neuroblastoma, a rare cancer that most often affects children aged five and under.
Mar 11, 2015
0
6